Assenagon Asset Management S.A. Has $4.23 Million Holdings in Molina Healthcare, Inc $MOH

Assenagon Asset Management S.A. decreased its stake in Molina Healthcare, Inc (NYSE:MOH) by 88.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 31,703 shares of the company’s stock after selling 239,521 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Molina Healthcare were worth $4,226,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Baird Financial Group Inc. acquired a new position in Molina Healthcare during the first quarter valued at approximately $210,000. NewEdge Advisors LLC raised its holdings in Molina Healthcare by 33.4% in the first quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock worth $364,000 after purchasing an additional 277 shares during the period. Jones Financial Companies Lllp raised its holdings in Molina Healthcare by 713.3% in the first quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock worth $544,000 after purchasing an additional 1,448 shares during the period. Goldman Sachs Group Inc. boosted its position in shares of Molina Healthcare by 19.4% during the first quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company’s stock worth $82,172,000 after purchasing an additional 40,531 shares in the last quarter. Finally, Woodline Partners LP bought a new position in shares of Molina Healthcare during the first quarter worth $1,541,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently commented on MOH shares. Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Saturday, May 2nd. Barclays boosted their target price on Molina Healthcare from $161.00 to $199.00 and gave the company an “underweight” rating in a research note on Tuesday, May 26th. Cantor Fitzgerald raised their price target on Molina Healthcare from $144.00 to $209.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Robert W. Baird lifted their price objective on Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Finally, UBS Group boosted their price objective on Molina Healthcare from $180.00 to $202.00 and gave the company a “neutral” rating in a research report on Friday, May 22nd. Three investment analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $184.81.

Insider Buying and Selling at Molina Healthcare

In other news, CAO Maurice Hebert sold 600 shares of the stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the transaction, the chief accounting officer directly owned 12,815 shares in the company, valued at $2,454,713.25. This represents a 4.47% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the transaction, the insider owned 67,175 shares of the company’s stock, valued at $12,502,611. The trade was a 20.96% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is currently owned by insiders.

Molina Healthcare Trading Down 0.3%

NYSE MOH opened at $229.12 on Tuesday. Molina Healthcare, Inc has a 52 week low of $121.06 and a 52 week high of $311.52. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63. The stock’s 50 day moving average price is $188.09 and its two-hundred day moving average price is $168.94. The stock has a market capitalization of $11.94 billion, a price-to-earnings ratio of 67.79 and a beta of 0.80.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. The company had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm’s revenue was down 3.1% compared to the same quarter last year. During the same period last year, the company earned $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, analysts anticipate that Molina Healthcare, Inc will post 5.23 earnings per share for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.